Catch Up on Possible End-of-Year Legislative Action and FY 2025 Appropriations Updates – Liver Health Policy Update
Congress is entering the August recess period. Nevertheless, patients are increasingly signaling to policymakers their frustration related to coverage challenges and over-zealous utilization management practices such as non-medical switching and other barriers to care. And appropriations bills are out for FY 2025!
Fatty Liver Disease Affects Millions, But the Future for Treatment Remains Brighter Than Ever – Fatty Liver Disease News
The recent FDA approval of resmetirom, which offers hope for those with moderate-to-advanced liver scarring, marks a breakthrough in treatment.
Growing Awareness between Alcohol and Cancer Risk – Liver Cancer News
Thank you for reading Liver Cancer News! Liver cancer is associated with low five-year survival rates, often due to late-stage diagnosis of the disease.
FDA’s New Rare Disease Innovation Hub may accelerate rare liver disease treatment – Pediatric & Rare Liver Diseases News
Ipsen Pharmaceuticals has just shared exciting news for rare liver disease patients with cholestasis.
Available Today! New Patient Assistance & Provider Resources – Fatty Liver Disease News
Trauma-informed, patient-led consultations to build trust and enhance medical care are important to clinical care for liver health, Dr. Julia Wattacheril, Director of the MASLD Program at Columbia’s Center for Liver Disease and Transplantation, has emphasized.